이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
AlzChem Group 관리
관리 기준 확인 2/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Andreas Niedermaier
최고 경영자
€1.5m
총 보상
CEO 급여 비율 | 20.9% |
CEO 임기 | 12.7yrs |
CEO 소유권 | n/a |
경영진 평균 재임 기간 | 6.6yrs |
이사회 평균 재임 기간 | 11.1yrs |
최근 관리 업데이트
Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being
May 01AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05Recent updates
A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)
Jun 04AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising
May 08Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being
May 01AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 26Is AlzChem Group (ETR:ACT) A Risky Investment?
Apr 11AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More
Mar 07Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching
Nov 01Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?
Oct 12AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
May 06AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05
Apr 05AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
Mar 04AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year
Apr 24AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00
Mar 29AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00
Feb 27AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 23Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?
Jun 10At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?
Apr 07AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?
Mar 23AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price
Mar 10Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 24Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)
Feb 11Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year
Aug 07Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?
Jul 20Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?
Jul 03CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Mar 31 2024 | n/a | n/a | €39m |
Dec 31 2023 | €2m | €315k | €35m |
Sep 30 2023 | n/a | n/a | €30m |
Jun 30 2023 | n/a | n/a | €28m |
Mar 31 2023 | n/a | n/a | €30m |
Dec 31 2022 | €818k | €315k | €30m |
Sep 30 2022 | n/a | n/a | €29m |
Jun 30 2022 | n/a | n/a | €28m |
Mar 31 2022 | n/a | n/a | €27m |
Dec 31 2021 | €890k | €300k | €28m |
Sep 30 2021 | n/a | n/a | €27m |
Jun 30 2021 | n/a | n/a | €26m |
Mar 31 2021 | n/a | n/a | €23m |
Dec 31 2020 | €786k | €300k | €20m |
Sep 30 2020 | n/a | n/a | €16m |
Jun 30 2020 | n/a | n/a | €17m |
Mar 31 2020 | n/a | n/a | €17m |
Dec 31 2019 | €915k | €260k |